Blockchain Registration Transaction Record

Clene Inc. to Present Breakthrough Neurodegenerative Disease Treatments at Emerging Growth Conference

Clene Inc. (NASDAQ: CLNN) to present at Emerging Growth Conference on Aug 20, 2025, showcasing treatments for ALS, Parkinson's, and MS. Live webcast available.

This news is significant as it highlights Clene Inc.'s ongoing efforts to develop treatments for neurodegenerative diseases, which affect millions worldwide. Their participation in the Emerging Growth Conference offers a glimpse into potential future therapies that could improve the quality of life for patients with ALS, Parkinson's, and multiple sclerosis. The advancements in mitochondrial health and neuronal function research could pave the way for groundbreaking treatments in the biopharmaceutical field.